Published in J Stroke Cerebrovasc Dis on March 02, 2009
Therapeutic hypothermia for brain ischemia: where have we come and where do we go? Stroke (2010) 1.49
Hypothermia for acute brain injury--mechanisms and practical aspects. Nat Rev Neurol (2012) 1.28
Brain temperature: physiology and pathophysiology after brain injury. Anesthesiol Res Pract (2012) 1.00
Investigational therapies for ischemic stroke: neuroprotection and neurorecovery. Neurotherapeutics (2011) 0.98
Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation? Antioxid Redox Signal (2010) 0.94
Therapeutic hypothermia in stroke and traumatic brain injury. Front Neurol (2011) 0.91
Temperature affects thrombolytic efficacy using rt-PA and eptifibatide, an in vitro study. Ther Hypothermia Temp Manag (2012) 0.90
In cold blood: intraarteral cold infusions for selective brain cooling in stroke. J Cereb Blood Flow Metab (2014) 0.84
Application of mild therapeutic hypothermia on stroke: a systematic review and meta-analysis. Stroke Res Treat (2012) 0.83
Rapid Induction of COOLing in Stroke Patients (iCOOL1): a randomised pilot study comparing cold infusions with nasopharyngeal cooling. Crit Care (2014) 0.83
Critical care for patients with massive ischemic stroke. J Stroke (2014) 0.83
Mild hypothermia reduces tissue plasminogen activator-related hemorrhage and blood brain barrier disruption after experimental stroke. Ther Hypothermia Temp Manag (2013) 0.82
Caffeinol at the receptor level: anti-ischemic effect of N-methyl-D-aspartate receptor blockade is potentiated by caffeine. Stroke (2009) 0.78
Combination of therapeutic hypothermia and other neuroprotective strategies after an ischemic cerebral insult. Curr Neuropharmacol (2014) 0.76
Winning a won game: caffeine panacea for obesity syndemic. Curr Neuropharmacol (2010) 0.75
Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research. Biomed Res Int (2017) 0.75
Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev (1999) 6.26
Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science (1989) 3.47
Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet (1996) 2.94
Caffeine consumption. Food Chem Toxicol (1996) 2.84
Induced hypothermia for acute stroke. Stroke (2007) 1.82
Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx (2004) 1.71
Clinical trial of induced hypothermia in comatose survivors of out-of-hospital cardiac arrest. Ann Emerg Med (1997) 1.55
Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us? Stroke (2004) 1.53
Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol (1995) 1.52
Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches. Cerebrovasc Dis (2004) 1.42
Neuroprotection and stroke: time for a compromise. J Neurochem (2007) 1.23
Intravascular Cooling in the Treatment of Stroke (ICTuS): early clinical experience. J Stroke Cerebrovasc Dis (2007) 1.14
Ethanol inhibits NMDA receptor-mediated excitotoxicity in rat primary neuronal cultures. Alcohol Clin Exp Res (1993) 1.01
Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience. Stroke (2003) 0.99
Alcohol, wine and platelet function. Biol Res (2004) 0.95
Combination of low dose ethanol and caffeine protects brain from damage produced by focal ischemia in rats. Neuropharmacology (2000) 0.95
Neuroprotection in acute ischemic stroke. Acta Neurol Belg (2005) 0.92
Caffeinol confers cortical but not subcortical neuroprotection after transient focal cerebral ischemia in rats. Brain Res (2004) 0.91
Mild hypothermia and outcome after CPR. Hypothermia for Cardiac Arrest (HACA) Study Group. Acta Anaesthesiol Scand Suppl (1997) 0.88
Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke. Stroke (2003) 0.86
Pharmacology of caffeinol in embolized rabbits: clinical rating scores and intracerebral hemorrhage incidence. Exp Neurol (2004) 0.84
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke (2009) 6.79
Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med (2004) 5.32
Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev (2009) 3.43
Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol (2012) 3.11
Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Stroke (2008) 2.58
Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet (2009) 2.50
Balloon guide catheter improves revascularization and clinical outcomes with the Solitaire device: analysis of the North American Solitaire Acute Stroke Registry. Stroke (2013) 2.46
Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab (2007) 2.31
Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results. Stroke (2010) 2.29
Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology (2002) 2.18
Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol (2011) 2.15
Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke (2005) 2.12
Diagnosis and initial management of cerebellar infarction. Lancet Neurol (2008) 2.08
Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2002) 2.08
Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab (2008) 2.06
Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol (2007) 2.05
Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke (2002) 1.97
Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res (2010) 1.89
Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest (2008) 1.81
Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab (2009) 1.80
Anticoagulation after cardioembolic stroke: to bridge or not to bridge? Arch Neurol (2008) 1.79
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75
The IVH score: a novel tool for estimating intraventricular hemorrhage volume: clinical and research implications. Crit Care Med (2009) 1.73
Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke (2006) 1.70
Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial. J Neuroimaging (2004) 1.69
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke (2012) 1.68
Changes in spleen size in patients with acute ischemic stroke: a pilot observational study. Int J Stroke (2012) 1.66
Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol (2011) 1.64
LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis (2008) 1.62
Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial. Stroke (2002) 1.62
Functional assessments in the rodent stroke model. Exp Transl Stroke Med (2010) 1.61
Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke (2007) 1.61
Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke (2004) 1.59
Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke. Arch Neurol (2008) 1.59
Accuracy of serial National Institutes of Health Stroke Scale scores to identify artery status in acute ischemic stroke. Circulation (2007) 1.58
Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann Neurol (2009) 1.52
Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke (2004) 1.50
Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med (2003) 1.48
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
A prospective, multicenter pilot study to evaluate the feasibility and safety of using the CoolGard System and Icy catheter following cardiac arrest. Resuscitation (2004) 1.46
The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med (2005) 1.44
The effect of activated factor VII for intracerebral hemorrhage beyond 3 hours versus within 3 hours. Stroke (2008) 1.43
Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable. Stroke (2005) 1.42
A randomized, controlled trial to teach middle school children to recognize stroke and call 911: the kids identifying and defeating stroke project. Stroke (2007) 1.42
Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. J Neurosci (2009) 1.41
Thrombolysis in stroke despite contraindications or warnings? Stroke (2013) 1.40
Can comprehensive stroke centers erase the 'weekend effect'? Cerebrovasc Dis (2008) 1.39
Feasibility of carotid artery stenting in patients with angiographic string sign. Catheter Cardiovasc Interv (2010) 1.39
Cell death in experimental intracerebral hemorrhage: the "black hole" model of hemorrhagic damage. Ann Neurol (2002) 1.39
Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci (2009) 1.38
Constraint-induced movement therapy during early stroke rehabilitation. Neurorehabil Neural Repair (2006) 1.34
Argatroban tPA stroke study: study design and results in the first treated cohort. Arch Neurol (2006) 1.33
Angiosarcoma: clinical and molecular insights. Ann Surg (2010) 1.33
The spot sign in intracerebral hemorrhage: the importance of looking for contrast extravasation. Cerebrovasc Dis (2009) 1.30
A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke. Stroke (2008) 1.30
Linking Notch signaling to ischemic stroke. Proc Natl Acad Sci U S A (2008) 1.28
15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. J Cereb Blood Flow Metab (2006) 1.26
IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res (2010) 1.24
Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res (2011) 1.24
Thrombolytic therapy for patients who wake-up with stroke. Stroke (2009) 1.23
Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging (2002) 1.23
Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke (2010) 1.22
Intravenous TPA for very old stroke patients. Eur Neurol (2005) 1.21
Intracerebral hemorrhage in cocaine users. Stroke (2010) 1.20